Pfizer and BioNTech have released an update on their COVID-19 vaccine, saying it’s now 95% effective and doesn’t have any serious side effects.
The vaccine will be submitted for regulatory approval within days.
The companies are expecting to produce 50 million doses of the vaccine by the end of the year, and 1.3 billion by the end of 2021.
The phase 3 data shows the vaccine is consistently effective across age, gender, race, and ethnicity demographics.
The announcement comes just a week after Pfizer first revealed their preliminary results and days after Moderna announced their vaccine is 94.5% effective.
